KRAS and malignant colon neoplasm: We have previously demonstrated that miR-143 reduces KRAS expression, chemo-sensitizes colon cancer cells to 5-fluorouracil8 and reduces tumour growth in vivo with increased apoptosis and reduced proliferation9.